Education/Training: Pre- and post-doctoral training in mental health service research, psychiatric epidemiology (NIMH T32), and addiction epidemiology (NIDA T32) from Johns Hopkins University School of Public Health (Maryland); Fellow of the NIH Summer Institute on the Design and Conduct of Randomized Clinical Trials.
Director: Duke Community Based Substance Use Disorder Research Program.
Node Principal Investigator/Director: Mid-Southern Node (Primary Care Networks), NIDA National Drug Abuse Treatment Clinical Trials Network.
Research interests: Opioid misuse, Opioid overdose, Opioid use disorder, Opioid addiction prevention and treatment, Pain and addiction, Chronic diseases and substance use disorders, diabetes, pharmacy services, Drug overdose, Polysubstance use and disorders, cannabis, alcohol, tobacco, hallucinogens, stimulants, SBIRT (substance use Screening, Brief Intervention, Referral to Treatment), EHR-based research and intervention, data science, psychometric analysis (IRT), epidemiology of addictions and comorbidity, behavioral health care integration, health services research (mental health disorders, substance use disorders, chronic diseases), nosology, research design/methods, HIV risk behavior.
FUNDED Research projects (Principal Investigator, PI):
Substance use/dependence (R03).
Treatment use for alcohol use disorders (R21).
Inhalant use & disorders (R21).
MDMA/hallucinogen use/disorders (R01).
Prescription opioid misuse/use disorders (R01).
Substance use disorders in adolescents (R01).
Substance use diagnoses & treatment (R21, R33).
Evolution of Psychopathology in the Population (R01: ECA Duke site PI).
Substance use disorders and treatment use among Asian Americans and Pacific Islanders (R01).
SBIRT in Primary Care (UG1: SBIRT, NIDA Clinical Trials Network).
Substance use screening tool validation in primary care (UG1: TAPS Tool, NIDA Clinical Trials Network).
Computer-facilitated intervention for adolescent marijuana use prevention (UG1: CAMP, NIDA CTN).
NIDA CTN Mid Southern Node (UG1: NIDA Clinical Trials Network).
EHR Data Element Study (UG1: EHR-DARE, NIDA Clinical Trials Network).
Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder (UG1: CTN-0075, NIDA Clinical Trials Network).
INSPIRE: Integrated Health Services to Reduce Opioid Use While Managing Chronic Pain (PCORI: Duke Site PI).
Evaluation of state-mandated acute and post-surgical pain-specific CDC opioid prescribing (R01: Duke Site PI).
Measuring Opioid Use Disorders in Secondary Electronic Health Records Data (Carolinas Collaborative Grant: Duke PI).
Developing a prevention model of alcohol use disorder for Pacific Islander young adults (R21: Duke subaward PI).
Committee member of the NIDA Asian American and Pacific Islander Researchers and Scholars Workgroup (NIDA AAPI Workgroup).
Education and Training
- D.Sc., Johns Hopkins University, 1997
- M.A., State University of New York at New Paltz, 1992
- Dissemination and Implementation Science in Cardiovascular Outcomes (DISCO)
- Developing a Prevention Model of Alcohol Use Disorder for Pacific Islander Young Adults
- Mid Southern Primary Care Networks Node
- Substance Abuse & Treatment Gaps in Asians, Pacific Islanders & Multiple-race Individuals
- Evaluation of state-mandated acute and post-surgical pain-specific CDC opioid prescribing guidelines